Vertex Pharmaceuticals | Kundefordringer



Trade Debtors Endring Dato
AbbVie USD 10.92B 553M 2024-12
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Arrowhead Research USD 2.5M 2.5M 2024-12
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Insmed USD 52.01M 9.7M 2024-12
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
J&J USD 16.02B 1.18B 2025-03
Merck USD 11.12B 1.06B 2024-12
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
United Therapeutics USD 322M 42.7M 2025-03
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Vertex Pharmaceuticals Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.